'80 mg' diaporamas de présentation

??????? ?????????????? ? ? ? E-mail:jxgao@lib.whu

695 views • 61 slides

CRESTOR TM (rosuvastatin) Clinical Overview

CRESTOR TM (rosuvastatin) Clinical Overview. CRESTOR and GALAXY Programme are trade marks of the AstraZeneca group of companies Licensed from Shionogi & Co. Ltd, Osaka, Japan. Contents. Disease Area Background Rosuvastatin Clinical Development Programme Efficacy Safety and Tolerability

4.2k views • 58 slides

I nuovi obiettivi terapeutici allo studio con statine.

753 views • 52 slides

Everything You Wanted to Know!

Everything You Wanted to Know!. Methadone 101. GOAL. To educate healthcare professionals about methadone pharmacotherapy the advantages and disadvantages and how to convert other opiods to methadone in order to provide safe effective and efficient pain management to patients at

738 views • 45 slides

New Therapeutic Options for Chronic Stable Angina

New Therapeutic Options for Chronic Stable Angina. New mechanistic approaches to chronic stable angina. CH 3. N. CH 3. O. O. H. O. N. CH 3. SO 2. N. N. NH. H. CH 3. OH. OCH 3. H. N. N. N. O. O. CH 3. Rho kinase inhibition (fasudil). Metabolic modulation (trimetazidine).

876 views • 44 slides

537 views • 39 slides

589 views • 38 slides

????

????. ?????????. Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). Prevalence: 0.5/100,000 in children, 2/100,000 in adult. CIDP and GBS. --Similarity:

725 views • 32 slides

729 views • 31 slides

ACC.08/SCAI-ACCi2 Clinical Trial Summary Slides

ACC.08/SCAI-ACCi2 Clinical Trial Summary Slides. ACCOMPLISH. Systolic blood pressure ? by amlodipine/benazapril, compared with HCTZ/benazapril by 0.7 mm Hg (p < 0.05)

467 views • 30 slides

Nutrient Bioavailability during Reproduction

Nutrient Bioavailability during Reproduction. Janet C. King, Ph.D. Director and Professor Western Human Nutrition Research Center University of California, Davis. Bioavailability. Fraction of the ingested nutrient that is used for normal physiological functions or storage.

519 views • 24 slides

330 views • 22 slides

Literature Review

339 views • 21 slides

The PROVE IT Trial

The PROVE IT Trial. Pravastatin or Atorvastatin Evaluation and Infection Therapy. Overview. Rationale Design Results and conclusions. What Is PROVE IT?. Background: Lipid-lowering therapy with statins reduces the risk of CV events, but the optimal level of LDL-C is unclear

955 views • 20 slides

Jack Springston, CIH, CSP William Esposito, CIH JinFu Liu, MS am bient labs, inc. New York, NY

Seasonal Variations in Indoor Air Quality Measurements In Metropolitan New York Commercial Buildings Between 1992-1998. Jack Springston, CIH, CSP William Esposito, CIH JinFu Liu, MS am bient labs, inc. New York, NY. Proactive IAQ Surveys. 757 surveys in 125 commercial office buildings

383 views • 17 slides

EXPLORE-Xa

EXPLORE-Xa.

235 views • 16 slides

EXPLORE-Xa

EXPLORE-Xa.

205 views • 16 slides

TNT: New data on intensive lipid lowering in stable CHD patients

TNT: New data on intensive lipid lowering in stable CHD patients. Hypothesis: Lowering LDL-C levels to well below 100 mg/dL could yield an incremental clinical benefit Participants: 10,001 patients with stable CHD and LDL-C 130-250 mg/dL Treatments: Atorvastatin 10 mg and 80 mg

277 views • 15 slides

EXPLORE-Xa

EXPLORE-Xa.

210 views • 15 slides

NSCLC Pancoast tumor

NSCLC Pancoast tumor. Swiss tumor board Bern – 26.3.2009. Dr. Christian Monnerat Département Pluridisciplaire d’Oncologie – Hôpital Neuchâtelois Service de génétique médicale – CHUV - Lausanne. NSCLC stage IIIB (treated in 2004) Summary of the case presented by Dr. Zappa.

521 views • 7 slides